Structure

Physi-Chem Properties

Molecular Weight:  973.4
Volume:  918.776
LogP:  0.166
LogD:  0.071
LogS:  -2.129
# Rotatable Bonds:  17
TPSA:  349.28
# H-Bond Aceptor:  23
# H-Bond Donor:  11
# Rings:  3
# Heavy Atoms:  25

MedChem Properties

QED Drug-Likeness Score:  0.031
Synthetic Accessibility Score:  7.005
Fsp3:  0.659
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.842
MDCK Permeability:  5.8803020692721475e-06
Pgp-inhibitor:  0.021
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.935
20% Bioavailability (F20%):  0.983
30% Bioavailability (F30%):  0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.037
Plasma Protein Binding (PPB):  64.67346954345703%
Volume Distribution (VD):  0.326
Pgp-substrate:  23.82118797302246%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.009
CYP2C19-inhibitor:  0.024
CYP2C19-substrate:  0.035
CYP2C9-inhibitor:  0.083
CYP2C9-substrate:  0.019
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.058
CYP3A4-inhibitor:  0.05
CYP3A4-substrate:  0.017

ADMET: Excretion

Clearance (CL):  1.887
Half-life (T1/2):  0.33

ADMET: Toxicity

hERG Blockers:  0.058
Human Hepatotoxicity (H-HT):  0.761
Drug-inuced Liver Injury (DILI):  0.976
AMES Toxicity:  0.015
Rat Oral Acute Toxicity:  0.562
Maximum Recommended Daily Dose:  0.97
Skin Sensitization:  0.532
Carcinogencity:  0.238
Eye Corrosion:  0.003
Eye Irritation:  0.003
Respiratory Toxicity:  0.348

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469444

Natural Product ID:  NPC469444
Common Name*:   Micropeptin 478-A
IUPAC Name:   [(2R)-3-[[(2S,5S,8S,11R,12S,15S,18S,21R)-2,8-bis[(2S)-butan-2-yl]-5-[(3-chloro-4-hydroxyphenyl)methyl]-15-[3-(diaminomethylideneamino)propyl]-21-hydroxy-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-2-hydroxy-3-oxopropyl] methanesulfonate
Synonyms:   Micropeptin 478 A
Standard InCHIKey:  QVGYFOADABRHJT-BYJMUUBVSA-N
Standard InCHI:  InChI=1S/C41H64ClN9O14S/c1-8-20(3)31-40(61)65-22(5)32(49-36(57)29(53)19-64-66(7,62)63)37(58)46-25(11-10-16-45-41(43)44)34(55)47-26-13-15-30(54)51(38(26)59)33(21(4)9-2)39(60)50(6)27(35(56)48-31)18-23-12-14-28(52)24(42)17-23/h12,14,17,20-22,25-27,29-33,52-54H,8-11,13,15-16,18-19H2,1-7H3,(H,46,58)(H,47,55)(H,48,56)(H,49,57)(H4,43,44,45)/t20-,21-,22+,25-,26-,27-,29+,30+,31-,32-,33-/m0/s1
SMILES:  CCC(C)C1C(=O)OC(C(C(=O)NC(C(=O)NC2CCC(N(C2=O)C(C(=O)N(C(C(=O)N1)CC3=CC(=C(C=C3)O)Cl)C)C(C)CC)O)CCCN=C(N)N)NC(=O)C(COS(=O)(=O)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1078917
PubChem CID:   46883093
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0001813] Peptidomimetics
        • [CHEMONTID:0001961] Depsipeptides
          • [CHEMONTID:0001994] Cyclic depsipeptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[11000050]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[11374973]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[12141855]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. Einan Reservoir in Israel n.a. PMID[12141855]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[18163584]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[18558743]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[18973386]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria water bloom of the cyanobacterium Microcystis aeruginosa n.a. n.a. PMID[19650639]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria bloom material Lake Kinneret, Israel n.a. PMID[22280481]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. Kibbutz Geva, Israel n.a. PMID[23153007]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. Water Reservoir near Kibbutz Hafetz Haim, Israel n.a. PMID[23718637]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria Bloom n.a. n.a. PMID[24261937]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[24642434]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[24868986]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[29405714]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria Bloom n.a. n.a. PMID[29847132]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[9249979]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. PMID[9842728]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. Database[Title]
NPO3288 Microcystis aeruginosa Species Microcystaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1720 Individual Protein Plasminogen Homo sapiens IC50 = 0.1 ug.mL-1 PMID[544079]
NPT2 Others Unspecified IC50 = 700.0 nM PMID[544080]
NPT2 Others Unspecified IC50 = 5200.0 nM PMID[544080]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469444 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.984 High Similarity NPC469445
0.9626 High Similarity NPC220060
0.962 High Similarity NPC469443
0.9223 High Similarity NPC469442
0.9223 High Similarity NPC277306
0.9128 High Similarity NPC25539
0.9115 High Similarity NPC219350
0.9115 High Similarity NPC194699
0.8871 High Similarity NPC102959
0.8824 High Similarity NPC60516
0.8684 High Similarity NPC302715
0.8594 High Similarity NPC473371
0.8548 High Similarity NPC473404
0.8333 Intermediate Similarity NPC51047
0.8238 Intermediate Similarity NPC61332
0.8238 Intermediate Similarity NPC240130
0.8118 Intermediate Similarity NPC46009
0.8103 Intermediate Similarity NPC470728
0.805 Intermediate Similarity NPC477551
0.8042 Intermediate Similarity NPC50016
0.804 Intermediate Similarity NPC477552
0.804 Intermediate Similarity NPC477550
0.8032 Intermediate Similarity NPC273755
0.8 Intermediate Similarity NPC22883
0.8 Intermediate Similarity NPC5719
0.8 Intermediate Similarity NPC210377
0.8 Intermediate Similarity NPC217804
0.7958 Intermediate Similarity NPC45037
0.7926 Intermediate Similarity NPC475204
0.7926 Intermediate Similarity NPC475123
0.7914 Intermediate Similarity NPC63040
0.788 Intermediate Similarity NPC1390
0.788 Intermediate Similarity NPC62104
0.7876 Intermediate Similarity NPC476321
0.7861 Intermediate Similarity NPC15068
0.7842 Intermediate Similarity NPC306804
0.7835 Intermediate Similarity NPC471526
0.7801 Intermediate Similarity NPC473354
0.7788 Intermediate Similarity NPC295795
0.7737 Intermediate Similarity NPC274198
0.7737 Intermediate Similarity NPC198254
0.7725 Intermediate Similarity NPC107938
0.7725 Intermediate Similarity NPC294516
0.7711 Intermediate Similarity NPC477638
0.7711 Intermediate Similarity NPC477632
0.7704 Intermediate Similarity NPC471048
0.7704 Intermediate Similarity NPC471049
0.7704 Intermediate Similarity NPC471050
0.7696 Intermediate Similarity NPC230611
0.7688 Intermediate Similarity NPC163961
0.7688 Intermediate Similarity NPC473305
0.768 Intermediate Similarity NPC269750
0.768 Intermediate Similarity NPC194671
0.7677 Intermediate Similarity NPC94862
0.7656 Intermediate Similarity NPC137627
0.7644 Intermediate Similarity NPC40234
0.7644 Intermediate Similarity NPC276506
0.7641 Intermediate Similarity NPC153554
0.7633 Intermediate Similarity NPC81845
0.7617 Intermediate Similarity NPC279871
0.7617 Intermediate Similarity NPC26108
0.7617 Intermediate Similarity NPC473402
0.7617 Intermediate Similarity NPC471165
0.7614 Intermediate Similarity NPC294951
0.7612 Intermediate Similarity NPC477631
0.76 Intermediate Similarity NPC477636
0.7598 Intermediate Similarity NPC323662
0.7592 Intermediate Similarity NPC280022
0.7577 Intermediate Similarity NPC196243
0.7562 Intermediate Similarity NPC473407
0.7562 Intermediate Similarity NPC473378
0.7526 Intermediate Similarity NPC155506
0.7526 Intermediate Similarity NPC159767
0.7526 Intermediate Similarity NPC476227
0.7524 Intermediate Similarity NPC473450
0.7488 Intermediate Similarity NPC328763
0.7474 Intermediate Similarity NPC248670
0.7448 Intermediate Similarity NPC209463
0.7435 Intermediate Similarity NPC63931
0.7415 Intermediate Similarity NPC477639
0.7411 Intermediate Similarity NPC119652
0.7411 Intermediate Similarity NPC97526
0.7409 Intermediate Similarity NPC129486
0.7385 Intermediate Similarity NPC475532
0.7368 Intermediate Similarity NPC469243
0.7368 Intermediate Similarity NPC471527
0.7358 Intermediate Similarity NPC478005
0.7347 Intermediate Similarity NPC165285
0.7347 Intermediate Similarity NPC17698
0.734 Intermediate Similarity NPC473580
0.7317 Intermediate Similarity NPC65714
0.7304 Intermediate Similarity NPC248822
0.7277 Intermediate Similarity NPC475544
0.7254 Intermediate Similarity NPC223207
0.725 Intermediate Similarity NPC477637
0.7234 Intermediate Similarity NPC473341
0.7227 Intermediate Similarity NPC478007
0.7216 Intermediate Similarity NPC304074
0.7216 Intermediate Similarity NPC471771
0.7216 Intermediate Similarity NPC290755
0.7212 Intermediate Similarity NPC471592
0.72 Intermediate Similarity NPC475409
0.72 Intermediate Similarity NPC170302
0.72 Intermediate Similarity NPC475564
0.7163 Intermediate Similarity NPC329295
0.7162 Intermediate Similarity NPC478008
0.7157 Intermediate Similarity NPC89831
0.71 Intermediate Similarity NPC473546
0.7073 Intermediate Similarity NPC96275
0.7053 Intermediate Similarity NPC262166
0.7041 Intermediate Similarity NPC61004
0.7033 Intermediate Similarity NPC80514
0.7032 Intermediate Similarity NPC326027
0.7026 Intermediate Similarity NPC471051
0.7026 Intermediate Similarity NPC471053
0.7026 Intermediate Similarity NPC471052
0.7018 Intermediate Similarity NPC326333
0.7011 Intermediate Similarity NPC239762
0.7011 Intermediate Similarity NPC163392
0.7011 Intermediate Similarity NPC48202
0.7005 Intermediate Similarity NPC81026
0.7 Intermediate Similarity NPC158277
0.6995 Remote Similarity NPC326349
0.6995 Remote Similarity NPC323336
0.6985 Remote Similarity NPC328494
0.6979 Remote Similarity NPC476268
0.6976 Remote Similarity NPC299806
0.6952 Remote Similarity NPC266741
0.6935 Remote Similarity NPC168861
0.6935 Remote Similarity NPC471568
0.6935 Remote Similarity NPC473693
0.6935 Remote Similarity NPC91953
0.6935 Remote Similarity NPC196091
0.6927 Remote Similarity NPC39431
0.6923 Remote Similarity NPC114806
0.6919 Remote Similarity NPC302597
0.6915 Remote Similarity NPC227778
0.6911 Remote Similarity NPC300443
0.6904 Remote Similarity NPC472923
0.6891 Remote Similarity NPC244509
0.6884 Remote Similarity NPC66490
0.6884 Remote Similarity NPC186617
0.6882 Remote Similarity NPC197921
0.6875 Remote Similarity NPC246591
0.6875 Remote Similarity NPC56685
0.6872 Remote Similarity NPC24617
0.6872 Remote Similarity NPC244336
0.6845 Remote Similarity NPC469360
0.6828 Remote Similarity NPC214988
0.6825 Remote Similarity NPC314083
0.6811 Remote Similarity NPC6570
0.6806 Remote Similarity NPC2501
0.6788 Remote Similarity NPC5194
0.6788 Remote Similarity NPC261934
0.6788 Remote Similarity NPC122590
0.6771 Remote Similarity NPC473491
0.6766 Remote Similarity NPC151030
0.6766 Remote Similarity NPC269383
0.675 Remote Similarity NPC328649
0.6732 Remote Similarity NPC475421
0.673 Remote Similarity NPC477526
0.6702 Remote Similarity NPC16188
0.6702 Remote Similarity NPC311658
0.6701 Remote Similarity NPC202198
0.6699 Remote Similarity NPC134413
0.6699 Remote Similarity NPC263507
0.6699 Remote Similarity NPC271958
0.6699 Remote Similarity NPC45112
0.6698 Remote Similarity NPC477527
0.6684 Remote Similarity NPC7817
0.6684 Remote Similarity NPC475168
0.6667 Remote Similarity NPC4910
0.6651 Remote Similarity NPC315542
0.665 Remote Similarity NPC297145
0.665 Remote Similarity NPC197743
0.6649 Remote Similarity NPC233702
0.6636 Remote Similarity NPC184933
0.6636 Remote Similarity NPC59827
0.6635 Remote Similarity NPC167763
0.6635 Remote Similarity NPC470112
0.6635 Remote Similarity NPC470903
0.6633 Remote Similarity NPC241794
0.6632 Remote Similarity NPC52748
0.6631 Remote Similarity NPC127741
0.6618 Remote Similarity NPC49315
0.6614 Remote Similarity NPC476989
0.6613 Remote Similarity NPC267237
0.6604 Remote Similarity NPC64140
0.6604 Remote Similarity NPC174122
0.6588 Remote Similarity NPC329731
0.6582 Remote Similarity NPC470902
0.6571 Remote Similarity NPC138083
0.6566 Remote Similarity NPC324850
0.6557 Remote Similarity NPC234069
0.6555 Remote Similarity NPC86678
0.655 Remote Similarity NPC73655
0.6535 Remote Similarity NPC254700
0.6528 Remote Similarity NPC135121
0.651 Remote Similarity NPC477217
0.651 Remote Similarity NPC315266

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469444 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7672 Intermediate Similarity NPD8303 Discontinued
0.7225 Intermediate Similarity NPD8019 Approved
0.7135 Intermediate Similarity NPD7495 Discontinued
0.7053 Intermediate Similarity NPD7523 Phase 3
0.6907 Remote Similarity NPD7118 Clinical (unspecified phase)
0.6755 Remote Similarity NPD8076 Discontinued
0.6746 Remote Similarity NPD6089 Clinical (unspecified phase)
0.6736 Remote Similarity NPD7303 Discontinued
0.6736 Remote Similarity NPD6689 Clinical (unspecified phase)
0.6699 Remote Similarity NPD7959 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8014 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7978 Discontinued
0.6651 Remote Similarity NPD5946 Clinical (unspecified phase)
0.6649 Remote Similarity NPD6078 Clinical (unspecified phase)
0.6634 Remote Similarity NPD7485 Phase 3
0.6634 Remote Similarity NPD7484 Phase 3
0.6632 Remote Similarity NPD5341 Clinical (unspecified phase)
0.663 Remote Similarity NPD3136 Phase 2
0.6601 Remote Similarity NPD7608 Discontinued
0.6583 Remote Similarity NPD3465 Clinical (unspecified phase)
0.6582 Remote Similarity NPD6670 Clinical (unspecified phase)
0.6558 Remote Similarity NPD6312 Discontinued
0.6546 Remote Similarity NPD6682 Clinical (unspecified phase)
0.6533 Remote Similarity NPD4018 Clinical (unspecified phase)
0.6526 Remote Similarity NPD7617 Discontinued
0.652 Remote Similarity NPD4652 Approved
0.6513 Remote Similarity NPD5348 Clinical (unspecified phase)
0.6505 Remote Similarity NPD5200 Clinical (unspecified phase)
0.6485 Remote Similarity NPD2098 Approved
0.648 Remote Similarity NPD4731 Phase 3
0.6476 Remote Similarity NPD3936 Clinical (unspecified phase)
0.6458 Remote Similarity NPD6681 Discovery
0.645 Remote Similarity NPD5356 Approved
0.645 Remote Similarity NPD5355 Approved
0.6421 Remote Similarity NPD6901 Phase 3
0.6415 Remote Similarity NPD6851 Approved
0.6415 Remote Similarity NPD6853 Approved
0.641 Remote Similarity NPD4588 Clinical (unspecified phase)
0.641 Remote Similarity NPD5308 Clinical (unspecified phase)
0.6404 Remote Similarity NPD8031 Discontinued
0.639 Remote Similarity NPD2890 Approved
0.639 Remote Similarity NPD2017 Approved
0.639 Remote Similarity NPD2888 Approved
0.639 Remote Similarity NPD2889 Approved
0.6387 Remote Similarity NPD6867 Clinical (unspecified phase)
0.6387 Remote Similarity NPD6866 Clinical (unspecified phase)
0.6386 Remote Similarity NPD2097 Approved
0.6379 Remote Similarity NPD6796 Discontinued
0.6373 Remote Similarity NPD6119 Clinical (unspecified phase)
0.6359 Remote Similarity NPD5309 Clinical (unspecified phase)
0.6351 Remote Similarity NPD4971 Clinical (unspecified phase)
0.6323 Remote Similarity NPD5152 Clinical (unspecified phase)
0.6308 Remote Similarity NPD7066 Clinical (unspecified phase)
0.6286 Remote Similarity NPD5096 Phase 3
0.6286 Remote Similarity NPD3933 Discontinued
0.6286 Remote Similarity NPD5095 Phase 3
0.6283 Remote Similarity NPD4782 Clinical (unspecified phase)
0.6281 Remote Similarity NPD7131 Phase 3
0.6279 Remote Similarity NPD3857 Clinical (unspecified phase)
0.6278 Remote Similarity NPD8162 Phase 2
0.6278 Remote Similarity NPD8163 Clinical (unspecified phase)
0.6263 Remote Similarity NPD6419 Discontinued
0.625 Remote Similarity NPD5137 Approved
0.6244 Remote Similarity NPD8290 Clinical (unspecified phase)
0.6244 Remote Similarity NPD5219 Approved
0.6244 Remote Similarity NPD5218 Approved
0.6237 Remote Similarity NPD6809 Clinical (unspecified phase)
0.623 Remote Similarity NPD4757 Clinical (unspecified phase)
0.6227 Remote Similarity NPD3659 Discontinued
0.6226 Remote Similarity NPD6297 Approved
0.6216 Remote Similarity NPD7811 Phase 3
0.6216 Remote Similarity NPD7810 Phase 3
0.6211 Remote Similarity NPD5729 Clinical (unspecified phase)
0.6186 Remote Similarity NPD7450 Phase 2
0.6165 Remote Similarity NPD4521 Clinical (unspecified phase)
0.6161 Remote Similarity NPD6256 Approved
0.6161 Remote Similarity NPD6255 Approved
0.6161 Remote Similarity NPD6254 Approved
0.6158 Remote Similarity NPD2541 Clinical (unspecified phase)
0.6158 Remote Similarity NPD7749 Clinical (unspecified phase)
0.6157 Remote Similarity NPD3803 Clinical (unspecified phase)
0.6126 Remote Similarity NPD829 Discontinued
0.6123 Remote Similarity NPD6905 Phase 2
0.6119 Remote Similarity NPD6058 Phase 2
0.6116 Remote Similarity NPD6253 Approved
0.6111 Remote Similarity NPD6237 Clinical (unspecified phase)
0.6109 Remote Similarity NPD8292 Phase 2
0.6094 Remote Similarity NPD4791 Clinical (unspecified phase)
0.6073 Remote Similarity NPD1330 Phase 2
0.6073 Remote Similarity NPD1329 Clinical (unspecified phase)
0.6061 Remote Similarity NPD1968 Approved
0.6061 Remote Similarity NPD1967 Approved
0.6059 Remote Similarity NPD6056 Approved
0.6059 Remote Similarity NPD6057 Approved
0.605 Remote Similarity NPD6088 Approved
0.6031 Remote Similarity NPD8172 Phase 2
0.6031 Remote Similarity NPD8173 Phase 2
0.6031 Remote Similarity NPD6073 Approved
0.603 Remote Similarity NPD8323 Discontinued
0.6027 Remote Similarity NPD4157 Discontinued
0.602 Remote Similarity NPD3536 Discontinued
0.6019 Remote Similarity NPD7132 Clinical (unspecified phase)
0.6011 Remote Similarity NPD3125 Approved
0.601 Remote Similarity NPD7836 Clinical (unspecified phase)
0.601 Remote Similarity NPD2976 Clinical (unspecified phase)
0.601 Remote Similarity NPD5296 Approved
0.6 Remote Similarity NPD4177 Approved
0.6 Remote Similarity NPD4175 Approved
0.5991 Remote Similarity NPD6863 Phase 2
0.599 Remote Similarity NPD3632 Clinical (unspecified phase)
0.599 Remote Similarity NPD6390 Discontinued
0.599 Remote Similarity NPD6646 Discontinued
0.5984 Remote Similarity NPD7963 Phase 3
0.5982 Remote Similarity NPD5872 Discontinued
0.5979 Remote Similarity NPD555 Phase 2
0.5975 Remote Similarity NPD4086 Phase 1
0.5973 Remote Similarity NPD3602 Clinical (unspecified phase)
0.5972 Remote Similarity NPD5192 Clinical (unspecified phase)
0.5966 Remote Similarity NPD3879 Approved
0.5959 Remote Similarity NPD5745 Approved
0.5951 Remote Similarity NPD8417 Discontinued
0.5949 Remote Similarity NPD5725 Approved
0.5942 Remote Similarity NPD4557 Approved
0.594 Remote Similarity NPD6189 Approved
0.594 Remote Similarity NPD6188 Approved
0.5939 Remote Similarity NPD2239 Approved
0.5939 Remote Similarity NPD3175 Clinical (unspecified phase)
0.5939 Remote Similarity NPD2240 Approved
0.5938 Remote Similarity NPD6919 Clinical (unspecified phase)
0.5931 Remote Similarity NPD1972 Approved
0.5931 Remote Similarity NPD1969 Clinical (unspecified phase)
0.5931 Remote Similarity NPD1973 Approved
0.593 Remote Similarity NPD6860 Clinical (unspecified phase)
0.5923 Remote Similarity NPD3878 Approved
0.5918 Remote Similarity NPD3554 Approved
0.5918 Remote Similarity NPD6852 Discontinued
0.5918 Remote Similarity NPD3552 Approved
0.5918 Remote Similarity NPD3555 Approved
0.5918 Remote Similarity NPD3553 Approved
0.5911 Remote Similarity NPD7613 Discontinued
0.5911 Remote Similarity NPD4186 Clinical (unspecified phase)
0.5907 Remote Similarity NPD2078 Clinical (unspecified phase)
0.5904 Remote Similarity NPD2562 Approved
0.5904 Remote Similarity NPD2561 Approved
0.5903 Remote Similarity NPD5542 Phase 2
0.5897 Remote Similarity NPD6187 Approved
0.5895 Remote Similarity NPD2585 Clinical (unspecified phase)
0.5891 Remote Similarity NPD5614 Approved
0.5891 Remote Similarity NPD5613 Approved
0.5888 Remote Similarity NPD3366 Approved
0.5882 Remote Similarity NPD2854 Approved
0.5882 Remote Similarity NPD2856 Approved
0.5882 Remote Similarity NPD2855 Approved
0.5882 Remote Similarity NPD8025 Phase 2
0.588 Remote Similarity NPD7574 Phase 2
0.5876 Remote Similarity NPD5747 Discontinued
0.5876 Remote Similarity NPD259 Phase 1
0.5874 Remote Similarity NPD2891 Approved
0.5867 Remote Similarity NPD823 Approved
0.5867 Remote Similarity NPD817 Approved
0.5867 Remote Similarity NPD2568 Approved
0.5867 Remote Similarity NPD5314 Approved
0.5865 Remote Similarity NPD7972 Discontinued
0.5865 Remote Similarity NPD4567 Approved
0.5865 Remote Similarity NPD4566 Approved
0.5864 Remote Similarity NPD5339 Clinical (unspecified phase)
0.586 Remote Similarity NPD8022 Clinical (unspecified phase)
0.5855 Remote Similarity NPD5746 Approved
0.585 Remote Similarity NPD5265 Approved
0.585 Remote Similarity NPD5264 Approved
0.5849 Remote Similarity NPD6107 Approved
0.5848 Remote Similarity NPD7429 Clinical (unspecified phase)
0.5846 Remote Similarity NPD4153 Approved
0.5846 Remote Similarity NPD6346 Approved
0.5842 Remote Similarity NPD3098 Discontinued
0.5841 Remote Similarity NPD7282 Approved
0.5838 Remote Similarity NPD6295 Approved
0.5838 Remote Similarity NPD6294 Approved
0.5837 Remote Similarity NPD5967 Approved
0.5833 Remote Similarity NPD4914 Approved
0.5833 Remote Similarity NPD7805 Phase 3
0.5825 Remote Similarity NPD597 Approved
0.5825 Remote Similarity NPD3455 Phase 2
0.5825 Remote Similarity NPD601 Approved
0.5825 Remote Similarity NPD598 Approved
0.5821 Remote Similarity NPD6676 Phase 2
0.5819 Remote Similarity NPD8066 Clinical (unspecified phase)
0.5817 Remote Similarity NPD2515 Approved
0.5817 Remote Similarity NPD3007 Approved
0.5811 Remote Similarity NPD779 Phase 2
0.581 Remote Similarity NPD4565 Clinical (unspecified phase)
0.581 Remote Similarity NPD4564 Clinical (unspecified phase)
0.5809 Remote Similarity NPD8356 Approved
0.5808 Remote Similarity NPD5301 Clinical (unspecified phase)
0.5806 Remote Similarity NPD5774 Approved
0.5806 Remote Similarity NPD5775 Approved
0.5806 Remote Similarity NPD7695 Clinical (unspecified phase)
0.5806 Remote Similarity NPD5485 Approved
0.5806 Remote Similarity NPD5484 Approved
0.5806 Remote Similarity NPD2218 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data